Document is current
Any future updates will be listed below
-
Authors
Hughes, Scott J.
Stec, Wojciech J.
Davies, Colin T. R. https://orcid.org/0000-0002-3156-543X
McGarry, David https://orcid.org/0000-0002-7087-0584
Williams, Alicia
Carrara, Marta
Del Barco Barrantes, Ivan
Harris, Rebecca
Tasegian, Anna https://orcid.org/0000-0001-6122-265X
Owens, Dominic D. G.
Fawcett, Alexander https://orcid.org/0000-0003-1880-3269
Hellicar, John
Azevedo, Aleksandra
Meier, Gregor P.
Runcie, Andrew C.
Greger, Liliana
O’Rourke, Martin
Churcher, Ian
Pass, Martin
Brown, Giles A.
Ciulli, Alessio https://orcid.org/0000-0002-8654-1670
Modis, Louise K. https://orcid.org/0000-0003-3103-4089
Testa, Andrea https://orcid.org/0000-0002-8973-9711
-
Funding
Funding for this research was provided by:
Amphista therapeutics
- License Information
-
More Information
Article History
Received: 31 December 2024
Accepted: 20 August 2025
First Online: 27 October 2025
Competing interests
: All co-authors are/were employees and/or shareholders of Amphista Therapeutics Ltd. The Ciulli laboratory at the University of Dundee receives or has received sponsored research support from Almirall, Amgen, Amphista Therapeutics, Boehringer Ingelheim, Eisai, Merck KaaG, Nurix Therapeutics, Ono Pharmaceutical and Tocris-Biotechne.
